There are differences in how European and American companies are managed. American companies have one primary goal: to make money. European companies often have multiple objectives. We present a hypothesis that American companies have better short-term profit performance when compared to their European counterparts. A comparison is performed with financial ratios using publicly available information. While U.S. companies tend to be fairly similar, the European businesses are not so homogeneous. We find that there are differences between the U.S. and European companies, and the hypothesis is supported by the analysis
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive a...
Drug regulation and pricing have put strong pressure on the cost-benefit ratio of the innovative pha...
This paper investigates which comparables selection method generates the most precise forecasts when...
Comparing the financial characteristics of firms in different countries and regions has been a popul...
The U.S. and Germany rank #1 and #3, respectively, in the world, in terms of the total amount of int...
Comparing the management characteristics of business firms in different countries has been a popular...
Introduction. The relevance of this study is in a need for a clear understanding of the mergers and...
Driven by the perspective of maximizing shareholder value (MSV), the U.S. biopharmaceutical industry...
Comparing the financial characteristics of different groups of firms with financial ratios has been ...
Abweichender Titel nach Übersetzung der Verfasserin/des VerfassersIn the asset pricing literature, a...
The objective of this study is to determine whether specific industries across countries or within c...
Germany and the United States are generally seen as the two competing systems of corporate governanc...
A Work Project, presented as part of the requirements for the Award of a Masters Degree in Managemen...
Background: Wu and Yeung have studied growth type with US companies to analyze capital structure and...
This paper provides a quantitative comparison of the financial patterns of non-financial European fi...
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive a...
Drug regulation and pricing have put strong pressure on the cost-benefit ratio of the innovative pha...
This paper investigates which comparables selection method generates the most precise forecasts when...
Comparing the financial characteristics of firms in different countries and regions has been a popul...
The U.S. and Germany rank #1 and #3, respectively, in the world, in terms of the total amount of int...
Comparing the management characteristics of business firms in different countries has been a popular...
Introduction. The relevance of this study is in a need for a clear understanding of the mergers and...
Driven by the perspective of maximizing shareholder value (MSV), the U.S. biopharmaceutical industry...
Comparing the financial characteristics of different groups of firms with financial ratios has been ...
Abweichender Titel nach Übersetzung der Verfasserin/des VerfassersIn the asset pricing literature, a...
The objective of this study is to determine whether specific industries across countries or within c...
Germany and the United States are generally seen as the two competing systems of corporate governanc...
A Work Project, presented as part of the requirements for the Award of a Masters Degree in Managemen...
Background: Wu and Yeung have studied growth type with US companies to analyze capital structure and...
This paper provides a quantitative comparison of the financial patterns of non-financial European fi...
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive a...
Drug regulation and pricing have put strong pressure on the cost-benefit ratio of the innovative pha...
This paper investigates which comparables selection method generates the most precise forecasts when...